Breakthrough software supporting improved prostate cancer detection

OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer.

Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS scoring.

imac background
 

OnQ Prostate Overlays

See what could have been missed.

Color Fusion Series
T2WI

Color Fusion Map

Automatically fuses the Restricted Signal Map with the anatomical image series to support anatomical localization.

Restricted Signal Map
T2WI

Restricted Signal Map

Shows areas of restricted diffusion with increased conspicuity compared to high b-value DWI.

”This technology has allowed for improved prostate cancer detection, specifically by helping distinguish aggressive lesions from normal prostate tissue.

Dr. Michael Liss, MDUrology, UT San Antonio
Benefits and features

How can OnQ Prostate improve your diagnosis?

1. McCammack KC, Kane CJ, Parsons JK, et al. In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI. Prostate Cancer Prostatic Dis. 2016;19(2):168-173. doi:10.1038/pcan.2015.61
2. McCammack KC, Schenker-Ahmed NM, White NS, et al. Restriction spectrum imaging improves MRI-based prostate cancer detection. Abdom Radiol (NY). 2016;41(5):946-953. doi:10.1007/s00261-016-0659-1

Diagnose & Plan Earlier

Easily discriminate prostate cancer from normal prostate tissue

Accurate Detection

Improves correlation with Gleason Score

Improve PI-RADS Performance

Has been shown to improve detection compared to mpMRI alone and improve inter-reader agreement.

1

Multi-Shell Diffusion Protocol

PI-RADs v2.1 compatible ADC maps — second acquisition for low b value series not required
2

Tissue Microstructure Model

3

Restricted Signal Map & Image Fusion

How it Works

Cutting-edge technology, simple workflow

Early Detection Matters

Early detection of cancer improves survival by enabling treatment at the earliest possible stage.

Unfortunately, most cancers are still detected at later stages when chances of survival are diminished. This year alone, more than 1.7 million people are expected to be diagnosed with cancer in the United States.

Cancer Survival Rates

When Diagnosed Early

Prostate

Breast

Colon & Rectum

Ovary

Cervical

Cancer Survival Rates

When Diagnosed Late

Prostate

Breast

Colon & Rectum

Ovary

Cervical

Source: Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER website April 2016.